EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chemoenzymatic Synthesis of Selegiline: An Imine Reductase-Catalyzed Approach

Yuliang Hu, Jinping Bao, Dongyu Tang, Shushan Gao, Fei Wang, Zhongtao Ding, Chengsen Cui iD

Molecules · 2024

DOI: 10.3390/molecules29061328 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Yuliang Hu und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Bioscience and Bioengineering, Jiangxi Agricultural University, Nanchang 330045, China. Hauptthemen laut MEDLINE: Oxidoreductases, Selegiline. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Strategic Priority Research Program, CAS, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

(R)-Homobenzylic amines are key structural motifs present in (R)-selegiline, a drug indicated for the treatment of early-stage Parkinson’s disease. Herein, we report a new short chemoenzymatic approach (in 2 steps) towards the synthesis of (R)-selegiline via stereoselective biocatalytic reductive amination as the key step. The imine reductase IR36-M5 mutant showed high conversion (97%) and stereoselectivity (97%) toward the phenylacetone and propargyl amine substrates, offering valuable biocatalysts for synthesizing alkylated homobenzylic amines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxidoreductasesSelegilineIminesStereoisomerismAminesAminationBiocatalysis

Stichwörter der Autor:innen

chemoenzymatic synthesishomobenzylic amineimine reductasereductive aminationsemi-rational design

Substanzen

OxidoreductasesSelegilineIminesAmines

Autor:innen und Institutionen

  • College of Bioscience and Bioengineering, Jiangxi Agricultural University, Nanchang 330045, China.
  • Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin 300308, China.
  • National Technology Innovation Center of Synthetic Biology, Tianjin 300308, China.

ORCID-Profile: Chengsen Cui

Förderung

  • National Key Research and Development Program of China
  • Strategic Priority Research Program, CAS
  • National Natural Science Foundation of China
  • "Innovative Cross Team" project, CAS
  • Young Scientists Innovation Promotion Association of CAS
  • Tianjin Synthetic Biotechnology Innovation Capacity Improvement Project
  • “Innovative Cross Team” project, CAS

Zitieren

APA

Hu, Y., Bao, J., Tang, D., Gao, S., Wang, F., Ding, Z., & Cui, C. (2024). Chemoenzymatic Synthesis of Selegiline: An Imine Reductase-Catalyzed Approach. Molecules. https://doi.org/10.3390/molecules29061328

Vancouver

Hu Y, Bao J, Tang D, Gao S, Wang F, Ding Z, et al. Chemoenzymatic Synthesis of Selegiline: An Imine Reductase-Catalyzed Approach. Molecules. 2024. doi:10.3390/molecules29061328

BibTeX
@article{Hu2024,
  author = {Hu, Yuliang and Bao, Jinping and Tang, Dongyu and Gao, Shushan and Wang, Fei and Ding, Zhongtao and Cui, Chengsen},
  title = {Chemoenzymatic Synthesis of Selegiline: An Imine Reductase-Catalyzed Approach},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29061328}
}
Kostenlos starten →